- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/22 - Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
Patent holdings for IPC class C07C 279/22
Total number of patents in this class: 36
10-year publication summary
|
5
|
3
|
3
|
1
|
4
|
2
|
0
|
2
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Albert Einstein College of Medicine, Inc. | 602 |
4 |
| Astellas Pharma Inc. | 1039 |
3 |
| Ultragenyx Pharmaceutical Inc. | 192 |
3 |
| Merck Patent GmbH | 5747 |
2 |
| Centre National de La Recherche Scientifique | 11111 |
2 |
| Biotron Limited | 13 |
2 |
| Tokyo University of Science Foundation | 446 |
2 |
| Universite de Strasbourg | 713 |
2 |
| Negio Therapeutics | 3 |
2 |
| The Regents of the University of California | 20902 |
1 |
| Toray Industries, Inc. | 7149 |
1 |
| Albert Einstein College of Medicine of Yeshiva University | 128 |
1 |
| Alcon, Inc. | 5911 |
1 |
| Glenmark Pharmaceuticals S.A. | 115 |
1 |
| Glytech, Inc. | 63 |
1 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 75 |
1 |
| Karos Pharmaceuticals, Inc. | 3 |
1 |
| Multi Formulations Ltd. | 9 |
1 |
| Nippon Soda Co., Ltd. | 884 |
1 |
| Regents of the University of Minnesota | 2809 |
1 |
| Other owners | 3 |